GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article
Routinely, a bolus of 5.000-10.000 IU human chorionic gonadotropin (hCG) is used for the final follicular maturation and ovulation as a standard method. HCG has the same effect of luteinizing hormone (LH) with long half-life. It has the long lutheotrophic effect which increases the risk of ovarian h...
Saved in:
Main Authors: | Ashraf Alyasin (Author), Shayesteh Mehdinejadiani (Author), Candidate. Marzieh Ghasemi (Author) |
---|---|
Format: | Book |
Published: |
Shahid Sadoughi University of Medical Science, Yazd, Iran,
2016-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Invitro fertilization outcome in triggering with GnRH agonist, Hcg or combination of GnRH agonist and Hcg
by: Alamtaj Samsami, et al.
Published: (2020) -
GnRH agonist versus GnRH antagonist in <it>in vitro</it> fertilization and embryo transfer (IVF/ET)
by: Depalo Raffaella, et al.
Published: (2012) -
Effect of slightly elevated progesterone on hCG trigger day on clinical pregnancy rate in GnRH-ant IVF/ICSI cycles
by: Jing Zhao, et al.
Published: (2022) -
Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF
by: Raoul Orvieto
Published: (2023) -
The effect of serum luteinizing hormone on trigger day with a GnRH antagonist protocol in IVF/ICSI treatment
by: Yanru Hou, et al.
Published: (2021)